Jonathan P Celli Selected Research

Jonathan P Celli Research Topics

23	Neoplasms (Cancer) 06/2022 - 12/2009
8	Ovarian Neoplasms (Ovarian Cancer) 03/2020 - 12/2009
4	Mouth Neoplasms (Oral Cancer) 06/2022 - 01/2019
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 09/2011
2	Adenocarcinoma 08/2021 - 01/2017
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019 - 05/2015
2	Photosensitivity Disorders (Photodermatitis) 01/2019 - 05/2015
1	Squamous Cell Carcinoma of Head and Neck 01/2020
1	Infections 10/2013
1	Hypoxia (Hypoxemia) 01/2011
1	Carcinoma (Carcinomatosis) 11/2010
1	Residual Neoplasm 11/2010
1	Neoplasm Micrometastasis 11/2010

16	1-phenyl-3,3-dimethyltriazene (PDT)IBA 06/2022 - 11/2010
7	Pharmaceutical PreparationsIBA 06/2022 - 01/2014
4	Proteins (Proteins, Gene)FDA Link 03/2020 - 11/2010
2	Carboplatin (JM8)FDA LinkGeneric 03/2020 - 11/2010
2	PlatinumIBA 03/2020 - 11/2010
2	protoporphyrin IXIBA 01/2020 - 05/2015
2	Aminolevulinic Acid (Levulan)FDA Link 01/2019 - 05/2015
2	Photosensitizing Agents (Photosensitizers)IBA 02/2018 - 01/2011
2	Verteporfin (Visudyne)FDA Link 02/2018 - 09/2011
1	CollagenIBA 01/2020
1	HydrogelsIBA 01/2020
1	AcidsIBA 01/2020
1	SolutionsIBA 01/2020
1	Riboflavin (Vitamin B2)FDA LinkGeneric 01/2020
1	Peptide Hydrolases (Proteases)FDA Link 04/2019
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2018
1	Gastric MucinsIBA 10/2013
1	GelsIBA 10/2013
1	MucinsIBA 10/2013
1	ErbB Receptors (EGF Receptor)IBA 05/2013
1	Indicators and Reagents (Reagents)IBA 05/2013
1	Biomarkers (Surrogate Marker)IBA 05/2013
1	Gemcitabine FDA Link 09/2011
1	5- ethylamino- 9- diethylaminobenzo(a)phenothiaziniumIBA 01/2011
1	Biological ProductsIBA 11/2010
1	EpitopesIBA 11/2010
1	Peptides (Polypeptides)IBA 12/2009
1	RADA16-IIBA 12/2009

14	Photochemotherapy (Photodynamic Therapy) 06/2022 - 11/2010
13	Therapeutics 06/2022 - 11/2010
5	Drug Therapy (Chemotherapy) 01/2021 - 11/2010
1	Lasers (Laser) 01/2019
1	Neoadjuvant Therapy 02/2018
1	Precision Medicine 01/2012